Nuvation Bio Inc. (NYSE:NUVB) is one of the best cancer stocks to invest in now. On February 9, Nuvation Bio Inc. (NYSE:NUVB) ...
Nuvation Bio recently finalized a protocol amendment to its global SIGMA study, expanding safusidenib into a Phase 3 registrational trial and broadening eligibility to include higher‑grade IDH1‑mutant ...
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced finalization of a protocol amendment to the ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results